Open access
Aug 2026
Integrated multi-omics analysis and functional experiments reveals PPAP2C as a potential prognostic biomarker and therapeutic target in breast cancer
PPAP2C exhibits the most significant overexpression pattern across 33 cancer types and was significantly associated with advanced clinical stages and aggressive subtypes (HER2+ and TNBC).
Xiao-Xi Lin, Li-Hang Cen, Si-Hui Yue et al.
· Frontiers in Pharmacology · 0 citations